BEHENNA, Douglas Carl,CHEN, Ping,FREEMAN-COOK, Kevin Daniel,HOFFMAN, Robert Louis,JALAIE, Mehran,NAGATA, Asako,NAIR, Sajiv Krishnan,NINKOVIC, Sacha,ORNELAS, Martha Alicia,PALMER, Cynthia Louise,RUI, E
申请号：
TN2019000039
公开号：
TN2019000039A1
申请日:
2017.07.31
申请国别(地区):
TN
年份:
2020
代理人:
摘要：
This invention relates to compounds of general Formula (I),thereof, and pharmaceutically acceptable salts thereof, in which R1, R2, R2A, R28, R3, R4 , R5A, R58, R6 , R7, R8, R9, p, q and rare as defined herein , to pharmaceutical compositions comprising such compounds and salts, and to methods of using such compounds, salts and compositions for the treatment of abnormal cell growth, including cancer.
